Neuland Laboratories Limited (BOM: 524558)

Neuland Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	875.75	454.16	50.91	24.36	112.04
Short-Term Investments	-	-	-	33.77	64.56	75
Cash & Short-Term Investments	875.75	875.75	454.16	84.68	88.91	187.04
Cash Growth	92.83%	92.83%	436.31%	-4.76%	-52.46%	21.15%
Accounts Receivable	-	3,760	3,687	2,380	2,207	1,920
Other Receivables	-	70.45	31.6	35.16	16.66	84.66
Receivables	-	3,830	3,719	2,415	2,223	2,005
Inventory	-	3,504	2,792	2,652	2,476	2,195
Prepaid Expenses	-	111.41	105.38	74.16	71.75	60.83
Other Current Assets	-	889.07	538.4	582.18	635.87	703.83
Total Current Assets	-	9,211	7,609	5,808	5,496	5,152
Property, Plant & Equipment	-	5,686	4,980	4,866	4,312	3,651
Long-Term Investments	-	12.79	5.25	4.97	4.4	36.57
Goodwill	-	2,795	2,795	2,795	2,795	2,795
Other Intangible Assets	-	24.58	13.01	21.2	34.98	19.58
Other Long-Term Assets	-	596.7	395.86	340.41	605.74	656.26
Total Assets	-	18,326	15,798	13,835	13,248	12,310
Accounts Payable	-	1,920	1,710	1,174	1,521	1,156
Accrued Expenses	-	1,060	626.39	451.21	480.95	272.44
Short-Term Debt	-	-	111.58	922.15	569.84	1,682
Current Portion of Long-Term Debt	-	375.86	361.07	344.84	250.58	140.45
Current Portion of Leases	-	36.79	30.92	26.46	25.32	15.66
Current Income Taxes Payable	-	0.81	104.02	-	-	-
Other Current Liabilities	-	883.53	1,446	713.08	837.07	310.42
Total Current Liabilities	-	4,277	4,390	3,632	3,685	3,576
Long-Term Debt	-	449.21	742.46	1,042	881.33	773.73
Long-Term Leases	-	92.03	38.48	69.4	95.86	25.78
Long-Term Unearned Revenue	-	-	-	-	0.3	202.8
Long-Term Deferred Tax Liabilities	-	604.39	582.99	566.99	597.57	477.81
Other Long-Term Liabilities	-	39.56	33.11	32.52	54.53	51.07
Total Liabilities	-	5,499	5,857	5,430	5,383	5,210
Common Stock	-	128.3	128.3	128.3	128.3	128.3
Additional Paid-In Capital	-	4,978	4,978	4,978	4,978	4,978
Retained Earnings	-	7,804	4,931	3,360	2,761	1,980
Comprensive Income & Other	-	-82.79	-96.38	-61.31	-2.01	13.64
Total Common Equity	12,827	12,827	9,941	8,405	7,865	7,100
Shareholders' Equity	12,827	12,827	9,941	8,405	7,865	7,100
Total Liabilities & Equity	-	18,326	15,798	13,835	13,248	12,310
Total Debt	953.9	953.9	1,284	2,405	1,823	2,637
Net Cash (Debt)	-78.14	-78.14	-830.34	-2,321	-1,734	-2,450
Net Cash Per Share	-6.09	-6.09	-64.72	-180.88	-135.15	-190.98
Filing Date Shares Outstanding	12.83	12.83	12.83	12.83	12.83	12.83
Total Common Shares Outstanding	12.83	12.83	12.83	12.83	12.83	12.83
Working Capital	-	4,934	3,219	2,176	1,811	1,576
Book Value Per Share	999.78	999.78	774.83	655.11	612.99	553.36
Tangible Book Value	10,008	10,008	7,133	5,589	5,035	4,285
Tangible Book Value Per Share	780.04	780.04	555.99	435.64	392.44	334.02
Land	-	287.48	107.43	107.43	107.43	107.43
Buildings	-	2,049	1,820	1,722	1,375	1,205
Machinery	-	5,336	4,635	4,337	3,754	2,945
Construction In Progress	-	458.91	405.66	204.57	172.5	237.51

Source: S&P Capital IQ. Standard template. Financial Sources.